Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans

被引:18
作者
Broglio, F
Prodam, F
Gottero, C
Destefanis, S
Me, E
Riganti, F
Giordano, R
Picu, A
Balbo, M
Van der Lely, AJ
Ghigo, E
Arvat, E
机构
[1] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, I-10126 Turin, Italy
[2] Erasmus Univ, Dept Internal Med, Div Endocrinol & Metab, Rotterdam, Netherlands
关键词
D O I
10.1111/j.1365-2265.2004.02038.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Acylated ghrelin, a gastric peptide, possesses a potent GH- but also significant ACTH/cortisol-releasing activity mediated by the activation of GH secretagogue receptors (GHS-R) at the hypothalamus-pituitary level. The physiological role of ghrelin in the control of somatotroph and corticotroph function is, however, largely unclear. Glucagon is known to induce a clear increase of GH, ACTH and cortisol levels in humans, at least after intramuscular administration. In fact, glucagon is considered to be a classical alternative to insulin-induced hypoglycaemia (ITT) for the combined evaluation of the function of GH and the hypothalamus-pituitary-adrenal (HPA) axis. We aimed to clarify whether ghrelin mediate the GH and corticotroph responses to intramuscular glucagon or ITT, which has recently been reported able to induce a surprising ghrelin decrease. SUBJECTS To this aim we enrolled six normal young male subjects [age (mean +/- SD): 29.0 +/- 8.0 years, body mass index (BMI) 21.9 +/- 2.5 kg/m(2)]. DESIGN AND MEASUREMENTS In all the subjects we studied ghrelin, GH, ACTH, cortisol and glucose levels after glucagon (GLU; 0.017 mg/kg intramuscularly), ITT (0.1 IU/kg insulin intravenously) or saline administration. RESULTS Saline infusion was not followed by any significant variation in ghrelin, GH and glucose levels while ACTH and cortisol showed the expected spontaneous morning trend toward a decrease. GLU administration increased (P < 0.01) circulating GH, ACTH and cortisol as well as insulin and glucose levels. ITT induced an obvious increase (P < 0.01) of GH, ACTH and cortisol levels. The ITT-induced increases in GH and ACTH, but not cortisol, levels were higher (P < 0.01) than those after GLU. Circulating ghrelin levels were not modified by GLU. On the other hand, ghrelin levels underwent a transient reduction (P < 0.01) after insulin-induced hypoglycaemia. CONCLUSIONS Ghrelin does not mediate the GH and ACTH responses to glucagon or to the ITT. In fact, ghrelin levels are not modified at all by glucagon and transiently decrease during the ITT. These findings support the assumption that ghrelin does not play a major role in the physiological control of somatotroph and corticotroph function.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 46 条
[11]   Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects [J].
Chapman, IM ;
Bach, MA ;
vanCauter, E ;
Farmer, M ;
Krupa, D ;
Taylor, AM ;
Schilling, LM ;
Cole, KY ;
Skiles, EH ;
Pezzoli, SS ;
Hartman, ML ;
Veldhuis, JD ;
Gormley, GJ ;
Thorner, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4249-4257
[12]   Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men [J].
Copinschi, G ;
VanOnderbergen, A ;
LHermiteBaleriaux, M ;
Mendel, CM ;
Caufriez, A ;
Leproult, R ;
Bolognese, JA ;
DeSmet, M ;
Thorner, MO ;
VanCauter, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2776-2782
[13]   Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion [J].
Date, Y ;
Nakazato, M ;
Hashiguchi, S ;
Dezaki, K ;
Mondal, MS ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Arima, T ;
Matsuo, H ;
Yada, T ;
Matsukura, S .
DIABETES, 2002, 51 (01) :124-129
[14]   The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans [J].
Di Vito, L ;
Broglio, F ;
Benso, A ;
Gottero, C ;
Prodam, F ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Ghigo, E ;
Arvat, E .
CLINICAL ENDOCRINOLOGY, 2002, 56 (05) :643-648
[15]   The influence of insulin on circulating ghrelin [J].
Flanagan, DE ;
Evans, ML ;
Monsod, TP ;
Rife, F ;
Heptulla, RA ;
Tamborlane, WV ;
Sherwin, RS .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (02) :E313-E316
[16]   Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome [J].
Ghigo, E ;
Arvat, E ;
Ramunni, J ;
Colao, A ;
Gianotti, L ;
Deghenghi, R ;
Lombardi, G ;
Camanni, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2439-2444
[17]   Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging [J].
Ghigo, E ;
Arvat, E ;
Gianotti, L ;
Grottoli, S ;
Rizzi, G ;
Ceda, GP ;
Boghen, MF ;
Deghenghi, R ;
Camanni, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 135 (04) :407-412
[18]   GLUCAGON STIMULATES GH SECRETION AFTER INTRAMUSCULAR BUT NOT INTRAVENOUS ADMINISTRATION - EVIDENCE AGAINST THE ASSUMPTION THAT GLUCAGON PER SE HAS A GH-RELEASING ACTIVITY [J].
GHIGO, E ;
BARTOLOTTA, E ;
IMPERIALE, E ;
BELLONE, J ;
CARDINALE, G ;
AIMARETTI, G ;
VALETTO, MR ;
CHERUBINI, V ;
MACCARIO, M ;
COCCHI, D ;
CAMANNI, F .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (11) :849-854
[19]   The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans [J].
Gnanapavan, S ;
Kola, B ;
Bustin, SA ;
Morris, DG ;
McGee, P ;
Fairclough, P ;
Bhattacharya, S ;
Carpenter, R ;
Grossman, AB ;
Korbonits, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2988-2991
[20]   A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans [J].
Hataya, Y ;
Akamizu, T ;
Takaya, K ;
Kanamoto, N ;
Ariyasu, H ;
Saijo, M ;
Moriyama, K ;
Shimatsu, A ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) :4552-4555